Jacobs Bruce N.'s Form 4 filing
Kymera Therapeutics, Inc. (KYMR) · filed Jan 14, 2022
- Accession no.
- 0000899243-22-002010
- Filed
- Jan 14, 2022
- Trade date
- Jan 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $777.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jacobs Bruce N.CIK 0001821074 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Common Stock | MOption exerciseAcquired | +15,000 | $2.08 | +$31,200 | 32,514 | Direct | |
| Jan 12, 2022 | Common Stock | SSaleDisposed | −6,427 | $51.21F2 | −$329,126.67 | 26,087 | Direct | |
| Jan 12, 2022 | Common Stock | SSaleDisposed | −7,151 | $52.13F3 | −$372,781.63 | 18,936 | Direct | |
| Jan 12, 2022 | Common Stock | SSaleDisposed | −1,422 | $53.27F4 | −$75,749.94 | 17,514 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 36,974 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.70 to $51.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.71 to $52.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.01 to $53.50. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.